Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
Recruiting
N/A
Interventional Study
Parkinson's Disease
Mild Cognitive Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 10 (estimated)
- Sponsor
- Helen M. Bronte-Stewart · Other
Who this trial is looking for
This trial is looking for people with Parkinson's disease who have mild cognitive impairment. Participants will receive a special type of brain stimulation over two years to help with thinking and movement problems.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with Parkinson's disease
- I am approved or planning to have deep brain stimulation
You may not be able to join if
- I have dementia
- I have unstable medical or psychiatric conditions
- I have a history of seizures
- I am pregnant
- I require MRI
- I cannot walk 100 feet without an assistive device
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the safety and tolerability of a novel deep brain stimulation (DBS) of the Subthalamic Nucleus (STN) and Nucleus Basalis of Meynert (NBM) to treat cognitive and cognitive-motor symptoms in individuals with Parkinson's disease. The main question it aims to answer is:
Is a combined deep brain stimulation approach targeting the STN and NBM with four DBS…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Parkinson's disease (PD)
* Approved (or planning on) for subthalamic nucleus (STN) deep brain stimulation (DBS)
* Willingness to withdraw from clinical medication regimen when necessary for research visits
* Ability to provide informed consent
Exclusion Criteria:…
Contacts